Rivaroxaban

Details

Files

Generic Name:

Rivaroxaban

Project Status:

Complete

Therapeutic Area:

Venous thromboembolism, prevention

Manufacturer:

Bayer Inc.

Brand Name:

Xarelto

Project Line:

Reimbursement Review

Project Number:

SF0239-000

NOC Status at Filing:

Post NOC

Submission Type:

Request For Advice

Indications:

Thromboembolism (venous) prevention

Recommendation Type:

N/A

Files

Submission Status Report View PDF

Last Updated : June 24, 2011